REVERT

This brand name is authorized in Brazil.

Active ingredients

The drug REVERT contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Atenolol UNII `50VV3VW0TI` - ATENOLOL
	Atenolol is a beta-blocker which is beta₁-selective, (i.e. acts preferentially on beta₁-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.
	Read more about Atenolol
`2`	Chlortalidone UNII `Q0MQD1073Q` - CHLORTHALIDONE
	Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action.
	Read more about Chlortalidone

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	509020110024807, 509020110024907, 509020110025007

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.